BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16008299)

  • 1. Tough cell to investors. Venture capitalists are wary of investing in companies in which risks in the science may not be rewarded by a health revenue stream.
    Moran N
    Sci Am; 2005 Jul; 293(1):A32-4. PubMed ID: 16008299
    [No Abstract]   [Full Text] [Related]  

  • 2. California dreaming.
    Nature; 2004 Oct; 431(7010):723. PubMed ID: 15483565
    [No Abstract]   [Full Text] [Related]  

  • 3. Australia's bio-regulatory framework: leading the way for stem cell research.
    Hill H
    J Biolaw Bus; 2004; 7(2):61-4. PubMed ID: 15460561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Companies balk at California's patent rules for stem cell research.
    Keim B
    Nat Med; 2007 Jan; 13(1):6. PubMed ID: 17206112
    [No Abstract]   [Full Text] [Related]  

  • 5. Stem cells: science and society.
    Adusumilli PS; Tuorto S; Patel AN
    Natl Med J India; 2006; 19(1):47-8. PubMed ID: 16570690
    [No Abstract]   [Full Text] [Related]  

  • 6. Leaders and laggards in the stem cell enterprise.
    Herrera S
    Nat Biotechnol; 2005 Jul; 23(7):775-7. PubMed ID: 16003350
    [No Abstract]   [Full Text] [Related]  

  • 7. Critics slate ethical leeway in California stem-cell proposal.
    Knight J
    Nature; 2004 Sep; 431(7006):232. PubMed ID: 15371993
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotechnology update: news and views.
    Debaets AM
    Ethics Med; 2005; 21(3):188-90. PubMed ID: 16475278
    [No Abstract]   [Full Text] [Related]  

  • 9. On the road to California.
    DeWitt N
    Nature; 2002 Dec; 420(6916 Suppl):A9. PubMed ID: 12510695
    [No Abstract]   [Full Text] [Related]  

  • 10. Schwarzenegger endorses stem-cell push.
    Knight J
    Nature; 2004 Oct; 431(7011):888. PubMed ID: 15496884
    [No Abstract]   [Full Text] [Related]  

  • 11. California prepares to roll out stem-cell funding.
    Dalton R
    Nature; 2005 Oct; 437(7060):800-1. PubMed ID: 16208332
    [No Abstract]   [Full Text] [Related]  

  • 12. Stem cells. Court rules in favor of California stem cell institute.
    Kaiser J
    Science; 2006 Apr; 312(5773):509. PubMed ID: 16645055
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges anticipated in removal of stem cell restrictions.
    Hutson S
    Nat Med; 2009 Jan; 15(1):3. PubMed ID: 19129765
    [No Abstract]   [Full Text] [Related]  

  • 14. California makes unprecedented commitment to fund stem cell research.
    Willard LA
    J Biolaw Bus; 2005; 8(2):47-8. PubMed ID: 16538814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From science to politics: the stem cell debate.
    Jennings CP
    Policy Polit Nurs Pract; 2005 Feb; 6(1):3-4. PubMed ID: 16443952
    [No Abstract]   [Full Text] [Related]  

  • 16. Joys match fears as California agrees to stem-cell proposal.
    Knight J
    Nature; 2004 Nov; 432(7014):135. PubMed ID: 15538329
    [No Abstract]   [Full Text] [Related]  

  • 17. The stem-cell state.
    Nature; 2004 Nov; 432(7014):131. PubMed ID: 15538323
    [No Abstract]   [Full Text] [Related]  

  • 18. Stem-cell issue moves up the US agenda.
    Wadman M
    Nature; 2007 Apr; 446(7138):842. PubMed ID: 17443152
    [No Abstract]   [Full Text] [Related]  

  • 19. California Stem Cell Research and Cures Act: what to expect from stem cell research?
    Panetta J; Wetherell J; Mehok M
    J Biolaw Bus; 2005; 8(4):3-12. PubMed ID: 16619447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Europe halts decisions on stem-cell patents.
    Schubert S
    Nature; 2005 Jun; 435(7043):720-1. PubMed ID: 15944658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.